The pulmonary fibrosis market is driven by the increasing prevalence of pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF), among the aging population, which boosts demand for ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

After a 16-year wait for the US Food and Drug Administration (FDA) to approve its lung imaging tool, Cyclopharm (ASX:CYC) is ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Johnson & Johnson’s JNJ fourth-quarter 2024 earnings came in at $2.04 per share, which beat the Zacks Consensus Estimate of ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Opioids, benzodiazepines and other medications used to treat these comorbidities and symptoms can increase a person's risk of ...

With numerous day trading chart providers available in the market, choosing the right one can be a daunting task. To assist you in this endeavor, Benzinga has compiled a comparison list of some of ...

The trial should help Novartis to persuade doctors and patients to switch from their tried-and-tested COPD medicines, as both can be fearful of losing control of the disease in a change of medication.

The importance of phenotyping chronic disease for personalized medicine Chronic diseases such as chronic obstructive pulmonary disease are due to a complex interaction of many genetic and ...

For this chart, we’ll assume your premeal blood ... People who use insulin or sulfonylurea medications to manage blood sugar should consider having a glucagon emergency kit on hand at all ...